124 related articles for article (PubMed ID: 3161934)
1. Activation of PRL secretion by combined treatment with cyproterone acetate and ethinylestradiol.
Valenti G; Vescovi PP; Gerra G; Rastelli G; Butturini U
J Endocrinol Invest; 1985 Jun; 8(3):269-72. PubMed ID: 3161934
[TBL] [Abstract][Full Text] [Related]
2. Long-term treatment of hirsutism: desogestrel compared with cyproterone acetate in oral contraceptives.
Porcile A; Gallardo E
Fertil Steril; 1991 May; 55(5):877-81. PubMed ID: 1827074
[TBL] [Abstract][Full Text] [Related]
3. Treatment of idiopathic hirsute women with two combinations of cyproterone acetate.
Salva P; Morer F; Ordoñez J; Rodriguez J
Int J Clin Pharmacol Res; 1983; 3(2):129-35. PubMed ID: 6237068
[TBL] [Abstract][Full Text] [Related]
4. [Inhibition of ovulation with 35 micrograms of ethinyl estradiol and 2 mg of cyproterone acetate (Diane 35)].
Spona J; Huber J; Schmidt JB
Geburtshilfe Frauenheilkd; 1986 Jul; 46(7):435-8. PubMed ID: 3093307
[TBL] [Abstract][Full Text] [Related]
5. A new association of ethinylestradiol (0.035 mg) cyproterone acetate (2 mg) in the therapy of polycystic ovary syndrome.
Falsetti L; Dordoni D; Gastaldi C; Gastaldi A
Acta Eur Fertil; 1986; 17(1):19-25. PubMed ID: 2941960
[TBL] [Abstract][Full Text] [Related]
6. Contraceptive and therapeutic effectiveness of two low-dose ethinylestradiol and cyproterone acetate regimens in the treatment of hirsute patients.
Venturoli S; Ravaioli B; Bagnoli A; Colombo FM; Macrelli S; Iadarola I; Vianello F; Mancini F; Flamigni C
Eur J Contracept Reprod Health Care; 1998 Mar; 3(1):29-33. PubMed ID: 9678070
[TBL] [Abstract][Full Text] [Related]
7. Hair growth and androgen responses in hirsute women treated with continuous cyproterone acetate and cyclical ethinyl oestradiol.
Jones DB; Ibraham I; Edwards CR
Acta Endocrinol (Copenh); 1987 Dec; 116(4):497-501. PubMed ID: 2962412
[TBL] [Abstract][Full Text] [Related]
8. Treatment of hirsutism by oral cyproterone acetate and percutaneous estradiol.
Kuttenn F; Rigaud C; Wright F; Mauvais-Jarvis P
J Clin Endocrinol Metab; 1980 Nov; 51(5):1107-11. PubMed ID: 6448264
[TBL] [Abstract][Full Text] [Related]
9. The effect of cyproterone acetate on pituitary-ovarian function and clinical symptoms in hirsute women.
Lunell NO; Zador G; Carlström K; Eneroth P; Patek E; Wager J
Acta Endocrinol (Copenh); 1982 May; 100(1):91-7. PubMed ID: 6214134
[TBL] [Abstract][Full Text] [Related]
10. The treatment of essential hirsutism in women with cyproterone acetate and ethinyl estradiol. Clinical and endocrine effects in 10 cases.
Frey H; Aakvaag A
Acta Obstet Gynecol Scand; 1981; 60(3):295-300. PubMed ID: 6455899
[TBL] [Abstract][Full Text] [Related]
11. [Cyproterone acetate and spironolactone compared in the therapy of female hirsutism].
Suraci C; Costa C; De Pedrini P
Clin Ter; 1983 Mar; 104(6):463-7. PubMed ID: 6221860
[No Abstract] [Full Text] [Related]
12. [The response to gonadotropin-releasing hormone in hirsutism after treatment with cyproterone acetate].
Kocijancic A; Pfeifer M; Prezelj J; Meden-Vrtovec H; Vrhovec I
Jugosl Ginekol Opstet; 1982; 22(1-2):16-9. PubMed ID: 6215543
[TBL] [Abstract][Full Text] [Related]
13. Effect of flutamide or cyproterone acetate on pituitary and testicular hormones in normal men.
Knuth UA; Hano R; Nieschlag E
J Clin Endocrinol Metab; 1984 Nov; 59(5):963-9. PubMed ID: 6237116
[TBL] [Abstract][Full Text] [Related]
14. Cyproterone acetate as initial treatment and maintenance therapy for hirsutism.
Holdaway IM; Croxson MS; Ibbertson HK; Sheehan A; Knox B; France J
Acta Endocrinol (Copenh); 1985 Aug; 109(4):522-9. PubMed ID: 2930987
[TBL] [Abstract][Full Text] [Related]
15. Cyproterone acetate: a study involving two volunteers with idiopathic hirsutism.
Barnes EW; Irvine WJ; Hunter WM; Ismail AA
Clin Endocrinol (Oxf); 1975 Jan; 4(1):65-73. PubMed ID: 1122656
[TBL] [Abstract][Full Text] [Related]
16. [Clinical use of antiandrogens in the female].
Moltz L; Schwartz U; Hammerstein J
Gynakologe; 1980 Mar; 13(1):1-17. PubMed ID: 6299908
[TBL] [Abstract][Full Text] [Related]
17. Antiandrogens and hirsutism.
Biffignandi P; Molinatti GM
Horm Res; 1987; 28(2-4):242-9. PubMed ID: 2969862
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the efficiency of anti-androgenic regimens consisting of spironolactone, Diane 35, and cyproterone acetate in hirsutism.
Sert M; Tetiker T; Kirim S
Acta Med Okayama; 2003 Apr; 57(2):73-6. PubMed ID: 12866746
[TBL] [Abstract][Full Text] [Related]
19. Treatment of severe hirsutism resulting from hyperandrogenism with the reverse sequential cyproterone acetate regimen.
Garner PR; Poznanski N
J Reprod Med; 1984 Apr; 29(4):232-6. PubMed ID: 6232380
[TBL] [Abstract][Full Text] [Related]
20. Low estrogen doses normalize testosterone and estradiol levels to the female range in transgender women.
Cunha FS; Domenice S; Sircili MHP; Mendonca BB; Costa EMF
Clinics (Sao Paulo); 2018; 73():e86. PubMed ID: 29723345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
